“memorial-sloan-kettering-cancer-center” Archives

Entry Author Date Location
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
Amid Nobel Prize Suspense, Making Sense Of Latest Gene-Editing News 10/06/15 National
Accelerator Adds $11.7M, Reels in AbbVie, WuxiTech to Back Startups 09/29/15 Seattle
Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial 09/29/15 Boston
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy 09/18/15 National
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer 08/31/15 New York
RainDance Technologies Cancels Long-Awaited IPO 08/24/15 Boston
Versant Walks Biotech “High Line” With a New Manhattan Incubator 08/24/15 New York
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
Welcome To The Sharing Economy. Cancer Researchers Are Next. 06/23/15 National
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials 04/15/15 Raleigh Durham
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
With $2B Market Cap and New Shareholder Rules, Juno Ready for Debut 12/18/14 Seattle
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
Seattle’s Fred Hutch Taps a Harvard, Merck Vet As New President 11/20/14 Seattle
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
What Early Looks From ASH Tell Us About Cancer Immunotherapy 11/07/14 National
Atara Bio Pays the Price for Delayed IPO, Sinks in Debut 10/16/14 San Francisco
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
West Coast Biotech Roundup: Ebola, Immunotherapy, Avalon & More 09/26/14 San Francisco
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
Page 1 of 3 next page »